Drug Withdrawal from the Market: Causes and Consequences

Rehan Haider*, Asghar Mehdi**, Geetha Kumari Das***
* Department of Pharmacy, University of Karachi, Pakistan.
** Head Department of Pharmacology, Fazaia RuthPfau Medical College,Air University Karachi.
*** GD Pharmaceutical Inc., OPJS University, Rajasthan.
Periodicity:July - December'2024

Abstract

The withdrawal of drugs from the market can happen for various reasons, including security concerns, lack of productivity, or commercial concerns. When a drug is remote, it can have important consequences for subjects, healthcare providers, drug associations, and regulatory instrumentalities. One of the basic causes of drug retraction is safety issues. Adverse backlashes, containing harsh side effects or surprising obstacles, may arise subsequently after a drug has been approved and retailed. For example, if a drug is established to increase the risk of heart attacks or strokes, supervisory instrumentalities grant permission to retract it from the market to assure public health. Another reason for retraction is the finding of lack of efficiency. If further studies reveal that a drug does not specify the engaged healing benefits or if superior alternatives perform, drug guests may willingly retract the product or regulatory instrumentalities may concede the possibility of its eviction. The results of drug removal can be widespread. Patients who depend on the withdrawn drug can face challenges in judging suitable substitutes, conceivably jolting their health consequences. Healthcare providers must regulate their situational plans and educate sufferers about alternative alternatives. Pharmaceutical companies grant permission to arouse economic losses on account of the expense of research, incidents, and marketing of the remote drug. Regulatory instrumentalities that grant permission face scrutiny concerning their authorization processes and post-retail surveillance devices. In conclusion, the removal of drugs from the market can have significant results for differing shareholders. It underscores the significance of exact security monitoring and constant judgment of the benefits and risks of drugs throughout their lifecycle.

Keywords

Drug Retraction, Advertise, Security Concerns, Lack Of Efficacy, Results, Unfavorable Responses, Regulatory Instrumentalities, Inmates, Healthcare Providers, Drug Companies, Community Health, Healing Benefits, Opportunities, Financial Deficits, Post-Advertise Following.

How to Cite this Article?

Haider, R., Mehdi, A., and Das, G. K. (2024). Drug Withdrawal from the Market: Causes and Consequences. Dale View's Journal of Clinical Pharmacology and Pharmacotherapeutics, 1(2), 8-13.

References

If you have access to this article please login to view the article or kindly login to purchase the article

Purchase Instant Access

Single Article

North Americas,UK,
Middle East,Europe
India Rest of world
USD EUR INR USD-ROW
Pdf 300
Online 300
Pdf & Online 500

Options for accessing this content:
  • If you would like institutional access to this content, please recommend the title to your librarian.
    Library Recommendation Form
  • If you already have i-manager's user account: Login above and proceed to purchase the article.
  • New Users: Please register, then proceed to purchase the article.